EnteroMedics Announces Proposed Underwritten Public Offering

Go back to EnteroMedics Announces Proposed Underwritten Public Offering

EnteroMedics (ETRM) Prices $20M Public Offering of Preferred Stock, Warrants

August 11, 2017 8:21 AM EDT

EnteroMedics Inc. (NASDAQ: ETRM), a developer of minimally invasive medical devices to treat obesity, metabolic diseases and other gastrointestinal disorders, today announced the pricing of an underwritten public offering of units for gross proceeds of $20 million, prior to deducting underwriting discounts and commissions and offering expenses payable by EnteroMedics.

The offering consists of units, priced at a public offering price of $1,000 per unit, comprised of one share of series B convertible preferred stock, which is convertible into 435 shares of common stock at a conversion price of $2.30 per share (the "preferred... More